Corrigendum to '18F-FDG PET for Dementia Evaluation: Co-pathologies, New Diseases, and Its Roles in The Era of Anti-Amyloid Treatment' [Seminar in Nuclear Medicine volume 55 (2025):526 -537/Article number YSNUC_51208].

IF 5.9 2区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Seminars in nuclear medicine Pub Date : 2025-09-25 DOI:10.1053/j.semnuclmed.2025.09.001

Tanyaluck Thientunyakit, Weerasak Muangpaisan, Satoshi Minoshima

引用次数: 0

查看原文本刊更多论文

“18F-FDG PET用于痴呆评估：共病理，新疾病及其在抗淀粉样蛋白治疗时代的作用”的勘误表[核医学研讨会卷55(2025):526 -537/文章编号YSNUC_51208]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in nuclear medicine 医学-核医学

CiteScore

9.80

自引率

6.10%

发文量

审稿时长

14 days

期刊介绍： Seminars in Nuclear Medicine is the leading review journal in nuclear medicine. Each issue brings you expert reviews and commentary on a single topic as selected by the Editors. The journal contains extensive coverage of the field of nuclear medicine, including PET, SPECT, and other molecular imaging studies, and related imaging studies. Full-color illustrations are used throughout to highlight important findings. Seminars is included in PubMed/Medline, Thomson/ISI, and other major scientific indexes.